A Phase 1 Study to Evaluate the Relative Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
Latest Information Update: 28 Feb 2022
At a glance
- Drugs Lofexidine (Primary)
- Indications Drug dependence; Opioid-related disorders; Substance withdrawal syndrome
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 04 Oct 2016 Status changed from recruiting to completed.
- 20 Jun 2016 New trial record